Literature DB >> 15793657

Use of tissue plasminogen activator for femoral artery thrombosis following transcatheter coil occlusion of patent ductus arteriosus.

K M Carlson1, J M Rutledge, B R Parker, R G Grifka.   

Abstract

Femoral artery thrombosis is an uncommon but potentially serious complication following pediatric cardiac catheterization. Management options include heparin infusion, thrombolytic therapy, and surgical thrombectomy. The use of thrombolytic agents following coil occlusion of shunts, collaterals, and patent ductus arteriosus (PDA) may be successful in resolving the femoral arterial thrombosis but may also reopen the device-occluded vessel. We report the successful use of tissue plasminogen activator for management of femoral artery thrombosis in a child following transcatheter PDA coil occlusion in which the PDA remained occluded.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793657     DOI: 10.1007/s00246-004-0599-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  9 in total

1.  Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children.

Authors:  A A Gupta; M Leaker; M Andrew; P Massicotte; L Liu; L N Benson; B W McCrindle
Journal:  J Pediatr       Date:  2001-11       Impact factor: 4.406

2.  Thrombolytic therapy for femoral artery thrombosis after pediatric cardiac catheterization.

Authors:  T Ino; L N Benson; R M Freedom; G A Barker; A Aipursky; R D Rowe
Journal:  Am Heart J       Date:  1988-03       Impact factor: 4.749

3.  The use of heparinization to prevent arterial thrombosis after percutaneous cardiac catheterization in children.

Authors:  M D Freed; J F Keane; A Rosenthal
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

4.  Surgical intervention for complications caused by femoral artery catheterization in pediatric patients.

Authors:  P H Lin; T F Dodson; R L Bush; V J Weiss; B S Conklin; C Chen; E L Chaikof; A B Lumsden
Journal:  J Vasc Surg       Date:  2001-12       Impact factor: 4.268

5.  Early and late results of thrombolytic therapy using tissue-type plasminogen activator to restore arterial pulse after cardiac catheterization in infants and small children.

Authors:  Duraisamy Balaguru; Muhammad Dilawar; Pamela Ruff; Wolfgang A K Radtke
Journal:  Am J Cardiol       Date:  2003-04-01       Impact factor: 2.778

6.  Rheolytic thrombectomy in the management of limb ischemia: 30-day results from a multicenter registry.

Authors:  Gary M Ansel; Barry S George; Charles F Botti; Thomas O McNamara; J Stephen Jenkins; Steven R Ramee; Kenneth Rosenfield; Alice A Noethen; Tejas Mehta
Journal:  J Endovasc Ther       Date:  2002-08       Impact factor: 3.487

7.  Complications of cardiac catheterization of neonates, infants, and children. A three-year study.

Authors:  P Stanger; M A Heymann; H Tarnoff; J I Hoffman; A M Rudolph
Journal:  Circulation       Date:  1974-09       Impact factor: 29.690

8.  Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.

Authors:  C Farnoux; O Camard; D Pinquier; M F Hurtaud-Roux; G Sebag; N Schlegel; F Beaufils
Journal:  J Pediatr       Date:  1998-07       Impact factor: 4.406

9.  Fibrinolytic therapy for femoral arterial thrombosis after cardiac catheterization in infants and children.

Authors:  D L Wessel; J F Keane; K E Fellows; H Robichaud; J E Lock
Journal:  Am J Cardiol       Date:  1986-08-01       Impact factor: 2.778

  9 in total
  1 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.